CELLAVISION AB (publ) Interim report for the period January 1 - September 30, 2007

2007-10-30 - English

  •    Net sales for the period increased by 40% and amounted to SEK 55.1 million (39.3). Net sales for the third quarter were SEK 21.1 million (11.6).
  •    Operating result for the period was SEK 0.1 million (-7.3), and for the third quarter SEK 3.8 million (-2.3).
  •    Net result per share amounted to SEK -0.01 million (-0.32) for the period.
  •    Liquid assets amounted to SEK 16.2 million at the end of the period.
  •    The new application for bodily fluids was previewed in the USA.
  •  
    Important events after the reporting period
  •    An evaluation of a potential future establishment on the Japanese market was initiated.
  •  


     
     
    CEO's comment
    "CellaVision is closing in on the goal of reaching positive turnover during 2007. However, the individual quarterly periods are difficult to compare because the company still is in a phase of rapid growth, and very dependent on its distributors and their success in sales," says Yvonne Mårtensson, CEO of CellaVision.
     
    "Yet another three Nordic hospitals have decided to use CellaVison's products during the third quarter. One of them - Malmö University Hospital, our very first client - has upgraded from the DiffMaster to a CellaVision DM96. In addition to continuing to fortify our position on markets where we are already established, we are also evaluating the Japanese market. Our products are well in line with the Japanese market, which is characterised by large automated laboratories."
     
    Yvonne Mårtensson
    CEO CellaVision AB
     
     
    For more information please contact:
    Yvonne Mårtensson, CEO. Tel: +46 708 33 77 82, e-mail: yvonne.martensson@cellavision.se
    Johan Wennerholm, CFO. Tel: +46 708 33 81 68, e-mail: johan.wennerholm@cellavision.se
     
    Download the report by pressing the link below.

    PDF version: Interim report for the period January 1 - September 30, 2007

    Subscribe to updates

    It's possible to subscribe to CellaVision's press releases, financial information by e-mail and SMS.

    Click here to register


    Information request

    Are you looking for some particular information about our company or our business?

    Click here to get in touch


    Analyst

    ABG Sundal Collier AB
    Sten Gustafsson
    +46 8 566 286 93

    Pareto Securities AB
    Christian Lee
    +46 8 402 52 67

     

    Access our Student Resources

    To access this resource, please provide the following information about yourself.